Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2010-07-19 17:40 |
VIVALIS SIGNE UNE LICENCE COMMERCIALE EB66® AVEC BOEHRINGER INGELHEIM VETMEDICA
|
French | 85.1 KB | ||
| 2010-07-08 17:45 |
CONTRAT DE LIQUIDITE BILAN SEMESTRIEL
|
French | 192.5 KB | ||
| 2010-07-08 17:45 |
DECLARATION ACTION ET DROIT DE VOTE
|
French | 7.0 KB | ||
| 2010-07-02 07:39 |
VIVALIS LAUNCHES A E30 MILLION RIGHTS ISSUE, SUPPORTED BY ITS REFERENCE SHAREHO…
|
English | 103.6 KB | ||
| 2010-07-02 07:30 |
VIVALIS LAUNCHES A E30 MILLION RIGHTS ISSUE, SUPPORTED BY ITS REFERENCE SHAREHO…
|
English | 103.7 KB | ||
| 2010-07-02 07:30 |
VIVALIS : AUGMENTATION DE CAPITAL DE E 30 MILLIONS AVEC MAINTIEN DU DPS SUIVIE …
|
French | 107.9 KB | ||
| 2010-06-23 17:40 |
VIVALIS ETEND SES CAPACITES DE R&D ET EMMENAGE DANS SON NOUVEAU LABORATOIRE
|
French | 99.3 KB | ||
| 2010-06-15 17:40 |
VIVALIS SIGNS A NEW COMMERCIAL LICENSE OF THE EB66® CELL LINE IN THE VETERINARY…
|
English | 78.8 KB | ||
| 2010-06-15 17:40 |
VIVALIS SIGNE UNE NOUVELLE LICENCE COMMERCIALE DE LA LIGNEE CELLULAIRE EB66® DA…
|
French | 86.8 KB | ||
| 2010-06-08 07:00 |
VIVALIS PARTNERS WITH SANOFI PASTEUR FOR THE DISCOVERY OF HUMAN MONOCLONAL ANTI…
|
English | 79.0 KB | ||
| 2010-06-08 07:00 |
VIVALIS SIGNE UN ACCORD AVEC SANOFI PASTEUR POUR LA RECHERCHE D'ANTICORPS MONOC…
|
French | 88.6 KB | ||
| 2010-06-04 17:45 |
VIVALIS DECLARATION ACTIONS ET DROIT DE VOTE
|
French | 6.9 KB | ||
| 2010-05-06 17:40 |
VIVALIS DECLARATION D4ACTIONS ET DROITS DE VOTE
|
French | 6.9 KB | ||
| 2010-05-04 17:40 |
VIVALIS: CHIFFRE D'AFFAIRES DU PREMIER TRIMESTRE 2010
|
French | 93.8 KB | ||
| 2010-05-04 17:40 |
VIVALIS REPORTS FIRST QUARTER 2010 REVENUES
|
English | 91.4 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
